Treatment-emergent psychiatric adverse events in patient-reported outcomes during ketamine use for major depressive disorder: a retrospective analysis.
Aleksander Kwaśny, Alina Wilkowska, Michał Pastuszak, Krzysztof Pastuszak, Wiesław Jerzy Cubała
Pharmacol Rep May 20, 2026 DOI: 10.1007/s43440-026-00867-1 via PubMed
Summary
AI-generated from the abstractA retrospective analysis of patient-reported outcomes found that psychiatric adverse events emerged during ketamine treatment for major depressive disorder. The text does not specify the frequency, severity, or nature of these events, nor does it provide comparative data or a control group. The analysis suggests that such events can occur, but the magnitude and clinical significance remain unclear based solely on the abstract.
Study at a glance
| Characteristics | Retrospective analysis Peer reviewed |
|---|---|
| Population | Patients with major depressive disorder using ketamine |
| Intervention | Ketamine |
| Key finding | Psychiatric adverse events were reported by patients during ketamine treatment for major depressive disorder. |
Abstract
Treatment-emergent psychiatric adverse events in patient-reported outcomes during ketamine use for major depressive disorder: a retrospective analysis.